Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYPAN: mycophenolate mofetil versus cyclophosphamide for induction of remission in childhood polyarteritis nodosa
ISRCTN75434563Phase 3Completed
- Sponsor
- University College London
- Start
- Nov 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in polyarteritis nodosa (PAN) comparing Cyclophosphamide with Mycophenolate mofetil (2 arms). Primary endpoint: Remission within 6 months of randomisation. Started Nov 2014; status: completed.
02
Drugs
mycophenolate mofetilcyclophosphamide
03
Conditions
polyarteritis nodosa (PAN)
Beyond the preview
Go deeper on ISRCTN75434563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN75434563.